Literature DB >> 1964768

Pain and opiate receptors: considerations for the design of positron emission tomography studies.

B Sadzot1, J J Frost.   

Abstract

Opiate receptors in the brain are the target of endogenous opioids and of exogenous synthetic opiates. These receptors play a major role in the modulation of pain perception. Using the appropriate ligands, positron emission tomography now allows investigators to monitor neuroreceptors in vivo. We have used (11)C-diprenorphine and the extremely potent mu opiate receptor agonist, (11)C-carfentanil, to image the distribution of opiate receptors in the brain and to quantify their density, their affinity, and their occupancy. Several important aspects of the in vivo opiate receptor labeling with positron emission tomography in relation to the study of pain are considered in this paper. Monitoring receptor occupancy by opiate drugs as a function of pain relief has the potential to reveal better ways to treat pain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964768      PMCID: PMC2190316     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  37 in total

1.  Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters.

Authors:  J J Frost; H N Wagner
Journal:  Brain Res       Date:  1984-07-02       Impact factor: 3.252

2.  Opiate receptor binding sites in human brain.

Authors:  A Pfeiffer; A Pasi; P Mehraein; A Herz
Journal:  Brain Res       Date:  1982-09-23       Impact factor: 3.252

3.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

Authors:  M A Mintun; M E Raichle; M R Kilbourn; G F Wooten; M J Welch
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

4.  Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.

Authors:  P Hartvig; K Bergström; B Lindberg; P O Lundberg; H Lundqvist; B Långström; H Svärd; A Rane
Journal:  J Pharmacol Exp Ther       Date:  1984-07       Impact factor: 4.030

5.  Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography.

Authors:  M A Mintun; M E Raichle; W R Martin; P Herscovitch
Journal:  J Nucl Med       Date:  1984-02       Impact factor: 10.057

6.  Quantitation in positron emission computed tomography: 5. Physical--anatomical effects.

Authors:  J C Mazziotta; M E Phelps; D Plummer; D E Kuhl
Journal:  J Comput Assist Tomogr       Date:  1981-10       Impact factor: 1.826

7.  Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

Authors:  B Dahlström; A Tamsen; L Paalzow; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

8.  Imaging dopamine receptors in the human brain by positron tomography.

Authors:  H N Wagner; H D Burns; R F Dannals; D F Wong; B Langstrom; T Duelfer; J J Frost; H T Ravert; J M Links; S B Rosenbloom; S E Lukas; A V Kramer; M J Kuhar
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

Review 9.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

10.  In vivo autoradiography: visualization of stress-induced changes in opiate receptor occupancy in the rat brain.

Authors:  T F Seeger; G A Sforzo; C B Pert; A Pert
Journal:  Brain Res       Date:  1984-07-09       Impact factor: 3.252

View more
  1 in total

1.  Pain imaging in the emerging era of molecular medicine.

Authors:  Christian S Stohler; Jon-Kar Zubieta
Journal:  Methods Mol Biol       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.